First Trust Advisors
WVE icon

First Trust Advisors’s Wave Life Sciences WVE Stock Holding History

First Trust Advisors’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$81.6K Buy
14,047
+529
+4% +$3.51K ﹤0.01% 2644
2026
Q1 		$98K Buy
13,518
+1,830
+16% +$23.8K ﹤0.01% 2586
2025
Q4 		$199K Buy
+11,688
New +$119K ﹤0.01% 2566

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GP
GSK plc London $602M AUM
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RAM
Readystate Asset Management Chicago, Illinois $2.93B AUM 18.57% 1-Year Est. Return

First Trust Advisors's WVE Position: Q2 2026 in Review

First Trust Advisors increased its Wave Life Sciences (WVE) stake by 3.9% in Q2 2026, buying an estimated $3.51K and bringing the position to 14,047 shares worth $81.6K. The position accounts for ﹤0.01% of the portfolio, ranked #2644.

First Trust Advisors first reported a position in WVE in Q4 2025 and has held it in 3 quarters since. The position peaked at $199K in Q4 2025. 239 funds tracked by Wall St. Rank hold WVE as of Q2 2026.

  • First Trust Advisors held 14,047 shares of Wave Life Sciences worth $81.6K as of Q2 2026.
  • First Trust Advisors bought 529 Wave Life Sciences shares in Q2 2026, an estimated $3.51K.
  • Wave Life Sciences made up ﹤0.01% of First Trust Advisors's portfolio in Q2 2026, its #2644 holding.
  • First Trust Advisors first reported a position in Wave Life Sciences in Q4 2025 and has held it in 3 quarters since.
  • First Trust Advisors's Wave Life Sciences position peaked at $199K in Q4 2025.
  • 239 funds tracked by Wall St. Rank held Wave Life Sciences as of Q2 2026.

Based on First Trust Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.